FDA Set To Make Key Decision On Restasis Generics

Akorn, Mylan And Teva Are In The Running For ANDA Approvals

 
• By Dean Rudge
  
Yes or no decision
Restasis ANDA filers are eyeing an FDA decision by the year end • Source: Shutterstock

More from Generics

More from Products